Call Us - We're Easy to Talk To (214) 999-9999

Glaxo Defends Handling of Avandia Heart Risks

GlaxoSmithKline said this week that a Senate report criticizing its handling of heart risks with its diabetes drug Avandia “mischaracterizes and distorts” the company’s record. As reported by the Associated Press, Glaxo is unhappy with the way the company’s response to reports of heart attacks caused by Avandia have been characterized by the Food and Drug Administration and the Senate Finance Committee. The Senate report, issued over the weekend, charged that Glaxo downplayed the drug’s safety risks and withheld important data from the FDA. “That suggestion is fundamentally flawed and contradicted by the record of extensive, ongoing interactions between GSK and the FDA,” states the company.

A report in May 2007 showed that Avandia users had a 43% higher risk of heart attacks than patients taking other diabetes drugs or no diabetes drugs at all.

Bob Kraft

I am a Dallas, Texas lawyer who has had the privilege of helping thousands of clients since 1971 in the areas of Personal Injury law and Social Security Disability.

About This Blog

The title of this blog reflects my attitude toward those government agencies and insurance companies that routinely mistreat injured or disabled people. As a Dallas, Texas lawyer, I've spent more than 45 years trying to help those poor folk, and I have been frustrated daily by the actions of the people on the other side of their claims. (Sorry if I offended you...)

If you find this type of information interesting or helpful, please visit my law firm's main website at You will find many more articles and links. Thank you for your time.

Find us on your preferred network